A variety of conditions decelerated Extremities Market growth, but new product introductions should accelerate future growth
Companies across the Extremities space reported a variety of conditions decelerating growth in Q222, including supply chain challenges, elective procedure cancellations due to COVID, facility staffing issues and reduced demand for trauma-related devices. WW Extremities Market growth slowed sequentially in Q222 compared to Q122. The US Extremities Market also saw slowing sequential growth. Moving forward, SmartTRAK expects Extremities market growth to accelerate as headwinds lessen and new product introductions boost revenue.
Among the many topics covered in detail in our comprehensive Q222 Extremities Market Recap* are:
- Complete Q222 Extremities Overview and Highlights
- SmartTRAK's Expert Analysis and Insights
- All Company News, Revenues, Data, Charts and Shares
- Top Players’ Results
- New Product Launches
- Merger & Acquisition Activity Highlights
- Q222 Regulatory Highlights
Several of the smaller market players also launched products during Q2. In April, Medline* UNITE Foot & Ankle announced the launch of their Calcaneal Fracture Plating System* and their IM Fibula Implant*. The two FDA-cleared products address ...
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click here.
